TORONTO, Nov. 5 /CNW/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical
company dedicated to the development and commercialization of cancer
therapies, announced today that it is participating in a GBM (glioblastoma
multiforme) Awareness Day as a co-host with Voices Against Brain Cancer.
